Effects of alcohol ingestion on estrogens in postmenopausal women

JAMA

Volumn 276, Issue 21, 1996, Pages 1747-1751

  Ginsburg, Elizabeth S ^a   Mello, Nancy K ^b   Mendelson, Jack H ^b   Barbieri, Robert L ^a   Teoh, Siew Koon ^b   Rothman, Micol ^b   Gao, Xiaoying ^a   Sholar, J Wallis ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ESTRADIOL; ESTROGEN; ESTRONE; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030459619     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.21.1747     Document Type: Article

References (47)

1. US Dept of Commerce, Bureau of the Census. Population projections of the United States by age, sex, race and hispanic origin 1993-2050. In: Current Population Reports, Series P-25, No. 1104. Washington, DC: US Government Printing Office; July 1995.
2. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995;85:6-10.
3. Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329: 1141-1146.
4. Genant RK, Baylink DJ, Gallagher JC, et al. Effect of estrone sulfate on postmenopausal bone loss. Obstet Gynecol. 1990;76:579-584.
5. Cauley JA, Seeley DG, Ensrud K, et al. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995;122:9-16.
6. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990;76:290-295.
7. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol. 1986;154:1181-1186.
8. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75-78.
9. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
10. Nabulsi A, Folsom AR, White A, et al, the Atherosclerosis Risk in Communities Study Investigators. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069-1075.
11. Boston Collaborative Drug Surveillance Program. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med. 1974;290:15-19.
12. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
13. Bergkvist L, Adami H-O, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321: 293-297.
14. Colditz GA, Stampfer MJ, Willett WC, et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 1990;264:2648-2653.
15. Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal oestrogens and breast cancer risk. Br J Cancer. 1986;54:825-832.
16. Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991; 265:1985-1990.
17. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267-273.
18. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet. 1994;344:1719-1723.
19. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988;260: 662-656.
20. Willett WC, Stampfer MJ, Colditz GA, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316:1174-1180.
21. Longnecker MP, Newcomb PA, Mittendorf R, et al. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst. 1995;87:923-929.
22. Longnecker MP. Do hormones link alcohol with breast cancer? J Natl Cancer Inst. 1993;85:692-693.
23. Gapstur SM, Potter JD, Sellers TA, Folsom AR. Increased risk of breast cancer with alcohol consumption in postmenopausal women. Am J Epidemiol. 1992;136:1221-1231.
24. Mendelson JH, Lukas SE, Mello NK, et al. Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology. 1988;94:464-467.
25. Ginsburg ES, Walsh BW, Gao X, et al. The effects of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol. J Soc Gynecol Invest. 1995;2:26-29.
26. Gavaler JS, Deal SR, Van Thiel DH, et al. Alcohol and estrogen levels in postmenopausal women: the spectrum of effect. Alcohol Clin Exp Res. 1993;17:786-790.
27. Zajchowski DA, Sager R. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol. 1991;5:1613-1623.
28. Selby PL, McGarrigle HHG, Peacock M. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women. Clin Endocrinol. 1989;30:241-249.
29. Yen SSC, Martin PL, Burnier AM, et al. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab. 1975;40:518-521.
30. Powers MS, Schenkel L, Darley PE, et al. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol. Am J Obstet Gynecol. 1985;152:1099-1106.
31. Mendelson JH, Mello NK, Cristofaro P, et al. Alcohol effects on naloxone-stimulated luteinizing hormone, prolactin and estradiol in women. J Stud Alcohol. 1987;48:287-294.
32. Mendelson JH, McGuire M, Mello NK. A new device for administering placebo alcohol. Alcohol. 1984;1:417-419.
33. Goldstein DB. Pharmacokinetics of alcohol. In: Mendelson JH, Mello NK, eds. Medical Diagnosis and Treatment of Alcoholism. New York, NY: McGraw-Hill Inc;1992:25-54.
34. Ginsburg ES, Walsh BW, Gao X, et al. The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril. 1995;63:1227-1230.
35. Mendelson JH, Mello NK, Ellingboe J. Acute alcohol intake and pituitary gonadal hormones in normal human females. J Pharmacol Exp Ther. 1981;218:23-26.
36. McNamee B, Grant J, Ratcliff J, Ratcliff W, Oliver J. Lack of effect of alcohol on pituitary-gonadal hormones in women. Br J Addict. 1979;74: 316-317.
37. Mendelson JH, Mello NK, Teoh SK, Ellingboe J. Alcohol effects on luteinizing hormone releasing hormone stimulated anterior pituitary and gonadal hormones in women. J Pharmacol Exp Ther. 1989; 250:902-909
38. Teoh SK, Mendelson JH, Mello NK, et al. Alcohol effects on hCG-stimulated gonadal hormones in women. J Pharmacol Exp Ther. 1990;254:407-411.
39. Gavaler JS, Rosenblum E. Exposure-dependent effects of ethanol on serum estradiol and uterus mass in sexually mature oophorectomized rats. J Stud Alcohol. 1987;48:295-303.
40. Reichman ME, Judd JE, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993;85:722-727.
41. Martins OO, Dada OA. The effect of alcohol on the in vitro absorption of estradiol and estrone sulphate in rat intestine. J Steroid Biochem. 1982; 16:265-268.
42. Cronholm T, Rudqvist U. Effects of ethanol metabolism on oxidoreduction and intermolecular hydrogen transfer at C-17 in steroid 3-sulfates in vivo. Biochim Biophys Acta. 1982;711:159-165.
43. Fishman J, Hellman L, Zumoff B, Gallagher TF. Influence of thyroid on hydroxylation of estrogen in man. J Clin Endocrinol Metab. 1965;25: 366-368.
44. Van Thiel DH, Tarter RE, Rosenblum E, Gavaler JS. Ethanol, its metabolism and gonadal effects. Adv Alcohol Subst Abuse. 1988;7:131-169.
45. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117: 1-9.
46. Jurgens RW, Downey LJ, Abernathy WD, Cutler NR, Conrad J. A comparison of circulating hormone levels in postmenopausal women receiving estrogen replacement therapy. Am J Obstet Gynecol. 1992;167:459-460.
47. Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.